The content on this site is intended for healthcare professionals only
Dr Gyawali speaks with ecancer at ASCO 2017 about financial toxicity of cancer treatment.
Financial toxicity of cancer treatment is now a well-recognised problem in cancer medicine leading to patient bankruptcy and even poor survival, including in high-income countries and countries with public health care systems.
Many oncologists, despite acknowledging the severity of financial toxicity as a problem, resign the responsibility of reducing the costs of cancer treatment to the government, industry, and oncology societies.
Read the short communication here.
Transforming cancer care in India: The Access Cancer Care Initiative
Burden and trends of breast cancer worldwide: Opportunities for prevention?
The added value of integrative medicine
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
GIST tumours and soft tissue sarcomas
Best practice in HRRm testing in patients with metastatic prostate cancer
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 4th - 10th, 2023
